What is Brian Zelickson's NPI number?

Brian Zelickson's National Provider Identifier (NPI) is 1336195148, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Brian Zelickson's specialty?

Brian Zelickson is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Brian Zelickson located?

Brian Zelickson's practice location on file with NPPES is 825 Nicollet Mall, Minneapolis, MN 55402-2606.

What is Brian Zelickson's phone number?

The practice phone number listed in the NPPES registry for Brian Zelickson is (612) 338-0711.

Does Brian Zelickson accept Medicare?

Brian Zelickson is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Brian Zelickson's NPI active?

Yes — Brian Zelickson's NPI (1336195148) is active in the NPPES registry as of the last update on 2010-07-01.

IndividualActiveAccepts Medicare

Brian Zelickson, M.D.

NPI 1336195148 · Dermatology Physician · Minneapolis, MN

Brian Zelickson, M.D. is a Dermatology Physician provider in Minneapolis, MN (NPI 1336195148).

Provider details

NPI number: 1336195148
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: No
License: 31389 (MN)

Practice location

825 Nicollet Mall

Suite 1002

Minneapolis, MN 55402-2606

Phone: (612) 338-0711

Fax: (612) 332-3663

Street-level locationGet directions

More MN providers

Mailing address

825 Nicollet Mall

Minneapolis, MN 55402-2606

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 31389 (MN)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(78/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
2,746 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	887	$40
Destruction of Precancer Skin Growth, 2-14 Growths17003	879	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	308	$93
Destruction of Precancer Skin Growth, 1 Growth17000	282	$56
Destruction of Skin Growth, 1-14 Growths17110	161	$116
Biopsy of Related Skin Growth, First Growth11102

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	101	46
Valacyclovir Hclbrand: Valacyclovir	80	54
Triamcinolone Acetonide	52	39
Metronidazole	52	24
Clindamycin Phosphate	33	16
Mometasone Furoate	33	27
Clobetasol Propionate	30	27
Desonide	30

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$131 across 4 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-05-25
Last updated: 2010-07-01

Frequently asked questions

What is Brian Zelickson's NPI number?: Brian Zelickson's National Provider Identifier (NPI) is 1336195148, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Brian Zelickson's specialty?: Brian Zelickson is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Brian Zelickson located?: Brian Zelickson's practice location on file with NPPES is 825 Nicollet Mall, Minneapolis, MN 55402-2606.
What is Brian Zelickson's phone number?: The practice phone number listed in the NPPES registry for Brian Zelickson is (612) 338-0711.
Does Brian Zelickson accept Medicare?: Brian Zelickson is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Brian Zelickson's NPI active?: Yes — Brian Zelickson's NPI (1336195148) is active in the NPPES registry as of the last update on 2010-07-01.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	887	$40
Destruction of Precancer Skin Growth, 2-14 Growths17003	879	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	308	$93
Destruction of Precancer Skin Growth, 1 Growth17000	282	$56
Destruction of Skin Growth, 1-14 Growths17110	161	$116
Biopsy of Related Skin Growth, First Growth11102

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

101

Valacyclovir Hclbrand: Valacyclovir

Triamcinolone Acetonide

Metronidazole

Clindamycin Phosphate

Mometasone Furoate

Clobetasol Propionate

Desonide

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$131 across 4 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments